Skip to content

Real-world clinical study of Quanduzhong capsules in the treatment of indications

Real-world clinical research on the prevention and treatment of primary osteoporosis with Quanduzhong Capsules

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000830
Enrollment
Unknown
Registered
2025-04-22
Start date
2024-03-02
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension/Osteoporosis/Knee osteoarthritis

Interventions

Hypertension:Quanduzhong Capsules
Osteoporosis:Quanduzhong Capsules
Knee Osteoarthritis:Quanduzhong Capsules

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 100 Years

Inclusion criteria

Inclusion criteria: Hypertension: 1. Aged 30-75 years both males and females are acceptable. 2. Meeting the diagnostic criteria for primary hypertension. 3. Corresponding to low-risk hypertension classification with seated diastolic blood pressure 90-99 mmHg or stage 1 hypertension with systolic blood pressure 140-160 mmHg. Osteoporosis: 1. Patients diagnosed with osteoporosis. 2. Age =45 years. 3. If previously received conservative treatment must complete =5-day washout period. 4. Signed informed consent form. According to the case inclusion criteria in the clinical study protocol all items 1-4 above should be answered "Yes" for subjects. Knee Osteoarthritis: 1. Patients diagnosed with knee osteoarthritis.

Exclusion criteria

Exclusion criteria: 1. Patients with suspected cases. 2. Patients with severe primary diseases involving the heart liver kidney hematopoietic system etc. 3. Patients allergic to the investigational drug. 4. Patients with mental illnesses. 5. Patients unable to comply with medical instructions for treatment.

Design outcomes

Primary

MeasureTime frame
Knee osteoarthritis symptom score;The rate of reaching the blood pressure target;Osteoporosis symptom score;

Secondary

MeasureTime frame
Visual Analogue Scale;Single symptom score;Hypertension Symptom Grading Scale;

Countries

China

Contacts

Public ContactTang Dezhi

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

dztang702@126.com64385700-9802

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026